SCHEMBL3660731

SCHEMBL3660731

Fc1ccc(/C=C(\CCl)c2ccc(F)cc2Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.41
LMNA P02545 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NPC1 O15118 2/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 3/20 0.36
HTT P42858 1/20 0.36
MAOB P27338 1/20 0.35
HSD11B1 P28845 1/20 0.35
MAPK1 P28482 1/20 0.34
HIF1A Q16665 1/20 0.34
TRPA1 O75762 2/20 0.33
PYGL P06737 2/20 0.33
ABCB11 O95342 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3766821 1.00 HPGD (0.41) HPGDLMNAMEN1CYP1A2MAPT
SCHEMBL2799017 0.82 MAPT (0.41) LMNAMEN1CYP1A2MAPTCYP2C9
SCHEMBL2799013 0.82 MAPT (0.41) LMNAMEN1CYP1A2MAPTCYP2C9
SCHEMBL3124317 0.81 MAOB (0.43) LMNAMEN1CYP1A2MAPTCYP2C9
SCHEMBL3124324 0.81 MAOB (0.43) LMNAMEN1CYP1A2MAPTCYP2C9
SCHEMBL3662523 0.80 NPC1 (0.39) HPGDMAPTKMT2ANPC1RAB9A
SCHEMBL3764145 0.80 NPC1 (0.39) HPGDMAPTKMT2ANPC1RAB9A
SCHEMBL3767511 0.79 ALDH1A1 (0.41) LMNAMEN1CYP1A2MAPTCYP2C9
SCHEMBL3767517 0.79 ALDH1A1 (0.41) LMNAMEN1CYP1A2MAPTCYP2C9
SCHEMBL3769663 0.79 NFE2L2 (0.41) HPGDMAPTNPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317515-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same BASF SE (DE) 2010-12-16 US disclosed
EP-2234488-A2 AZOLYLMETHYLOXIRANES, USE THEREOF AND AGENTS CONTAINING THE SAME BASF SE (DE) 2010-10-06 EP disclosed
WO-2009077443-A2 AZOLYLMETHYLOXIRANES, USE THEREOF AND AGENTS CONTAINING THE SAME BASF SE (DE) 2009-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317515-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same XDH, NOX5, TET1 HPGD 174/4885LMNA 4209/4885MEN1 1724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.